Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 3
2004 3
2005 2
2006 2
2007 2
2008 7
2009 6
2010 11
2011 11
2012 7
2013 6
2014 10
2015 11
2016 17
2017 13
2018 12
2019 6
2020 17
2021 21
2022 13
2023 10
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
Núñez J, de la Espriella R, Miñana G, Santas E, Llácer P, Núñez E, Palau P, Bodí V, Chorro FJ, Sanchis J, Lupón J, Bayés-Genís A. Núñez J, et al. Among authors: nunez e. Eur J Heart Fail. 2021 Sep;23(9):1445-1457. doi: 10.1002/ejhf.2295. Epub 2021 Jul 20. Eur J Heart Fail. 2021. PMID: 34241936 Free article. Review.
[Regression modeling strategies].
Núñez E, Steyerberg EW, Núñez J. Núñez E, et al. Rev Esp Cardiol. 2011 Jun;64(6):501-7. doi: 10.1016/j.recesp.2011.01.019. Epub 2011 Apr 29. Rev Esp Cardiol. 2011. PMID: 21531065 Free article. Review. Spanish.
Urine: an overlooked biomedium in heart failure?
la Espriella R, Bayés-Genís A, Núñez E, Núñez J. la Espriella R, et al. Among authors: nunez e. Biomark Med. 2020 Feb;14(3):165-168. doi: 10.2217/bmm-2019-0433. Epub 2020 Feb 14. Biomark Med. 2020. PMID: 32057256 No abstract available.
Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status.
Lorenzo M, Jacobs-Cachá C, Palau P, Amiguet M, Seller J, Núñez E, Espriella R, Górriz JL, Miñana G, Sanchis J, Bayés-Genis A, Soler MJ, Packer M, Núñez J; DAPA-VO2 Investigators. Lorenzo M, et al. Among authors: nunez e. JACC Heart Fail. 2023 Nov;11(11):1611-1622. doi: 10.1016/j.jchf.2023.07.010. Epub 2023 Sep 6. JACC Heart Fail. 2023. PMID: 37676213 Clinical Trial.
Clinical utility of antigen carbohydrate 125 in heart failure.
Núñez J, Miñana G, Núñez E, Chorro FJ, Bodí V, Sanchis J. Núñez J, et al. Among authors: nunez e. Heart Fail Rev. 2014 Sep;19(5):575-84. doi: 10.1007/s10741-013-9402-y. Heart Fail Rev. 2014. PMID: 23925386 Review.
Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction.
Lorenzo M, Miñana G, Palau P, Amiguet M, Seller J, Garcia Pinilla JM, Domínguez E, Villar S, DE LA Espriella R, Núñez E, Górriz JL, Valle A, Bodí V, Sanchis J, Bayés-Genis A, Núñez J; DAPA-VO2 Investigators. Lorenzo M, et al. Among authors: nunez e. J Card Fail. 2023 May;29(5):849-854. doi: 10.1016/j.cardfail.2023.02.008. Epub 2023 Mar 4. J Card Fail. 2023. PMID: 36871614 Clinical Trial.
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction.
Miñana G, de la Espriella R, Palau P, Amiguet M, Seller J, García Pinilla JM, Núñez E, Górriz JL, Valle A, Sanchis J, Bayés-Genís A, Núñez J; en representación de los investigadores del DAPA-VO2. Miñana G, et al. Among authors: nunez e. Rev Esp Cardiol (Engl Ed). 2023 Oct;76(10):783-792. doi: 10.1016/j.rec.2023.03.007. Epub 2023 Mar 22. Rev Esp Cardiol (Engl Ed). 2023. PMID: 36958534 Clinical Trial. English, Spanish.
163 results